Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2022—Verichem Laboratories announced the availability of a multilevel set of liquid-stable, ready-to-use clinical reference materials for the calibration and calibration verification of ammonia assays. The materials are universally compatible and can be used with a range of clinical testing systems, including from Abbott Diagnostics, Beckman Coulter, Roche Diagnostics, and Siemens Healthineers.
May 2022—Source Medical Products announced it is carrying CelLock, a kit that standardizes the preparation of formalin-fixed, paraffin-embedded cell blocks. Included in the kit is a proprietary product called CelLGel, which is used in concert with a proprietary filter to collect and process 99.7 percent of the initial patient specimen into the cell block. The filter is included in the cell block to provide a visual cue, the company says, to make the tasks of embedding and microtomy easier and more exacting. The cellular proteomic and genetic information within the specimen is preserved for immunohistochemical, molecular, and ancillary testing.
June 2022—Accelerate Diagnostics announced the release of new performance data on the Accelerate Arc module and blood culture kit.
June 2022—Tribun Health announced its expansion into the pharmaceutical market with the appointment of Loic Dartois as vice president of pharma. Dartois joined Tribun Health in March and is developing commercial offerings for the pharma industry. “Digital pathology data combined with best-in-class AI models has the power to improve treatments’ responses to a better targeted population,” Dartois said in a press release. “Thanks to its growing footprint in health care institutions in Europe and North America, Tribun Health is best positioned to support the pharmaceutical industry in its precision medicine transformation using an industry-leading digital pathology platform and deploying a thought leadership AI team.”
June 2020—Sysmex America has expanded its reagent portfolio by becoming a distributor of more than 450 Exbio single-color antibodies, cell stains, and buffering solutions. The company offers a comprehensive variety of analyte-specific reagent and research use only antibodies for immunophenotyping, cell staining and processing, and vitality assays, as well as for other research applications.
June 2022—Bio-Rad Laboratories introduced a range of antibodies specific to cemiplimab (Libtayo) that inhibit the binding of the drug to its target, human programmed death receptor-1. The ready-made antibodies are suitable for developing selective and sensitive assays for the bioanalysis and drug monitoring of cemiplimab.
June 2022—ZeptoMetrix announced the release of its NATtrol SARS-CoV-2 Omicron External Run Control, for research use only, to evaluate the performance of nucleic acid tests for determining the presence of SARS-CoV-2 omicron variant RNA. The control is formulated with purified, intact organisms and is for use with a real-time PCR thermal cycler. The product is available in six 0.5-mL vials and is refrigerator stable at 2° to 8°C.
June 2022—Memorial Sloan Kettering Cancer Center has awarded GRM Information Management a multiyear contract to store and manage pathology blocks and slides for the hospital’s clinical and research departments.
June 2022—Siemens Healthineers announced the FDA has granted breakthrough device designation for the Advia Centaur serum neurofilament light chain (sNfL) assay, developed in collaboration with Novartis Pharma. The assay quantitatively measures NfL in human serum and plasma and is intended to be used in conjunction with clinical, imaging, and laboratory findings as an aid in identifying adult patients with relapsing multiple sclerosis who are at lower risk, versus higher risk, of multiple sclerosis disease activity.
June 2022—DiaSorin announced that Luminex, a DiaSorin company, CE marked its xMAP NxTAG Gastrointestinal Pathogen Panel (GPP). The new panel is a multiplex test that detects nucleic acids from 16 clinically relevant bacterial, viral, and parasitic pathogens in stool samples on the Magpix system.
